ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Open Access
- 1 March 2013
- journal article
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 11 (2), 209-217
- https://doi.org/10.2174/1570159x11311020007
Abstract
The renin-angiotensin system (RAS) in brain is a crucial regulator for physiological homeostasis and diseases of cerebrovascular system, such as ischemic stroke. Overactivation of brain Angiotensin-converting enzyme (ACE) - Angiotensin II (Ang II) - Angiotensin II type 1 receptor (AT1R) axis was found to be involved in the progress of hypertension, atherosclerosis and thrombogenesis, which increased the susceptibility to ischemic stroke. Besides, brain Ang II levels have been revealed to be increased in ischemic tissues after stroke, and contribute to neural damage through elevating oxidative stress levels and inducing inflammatory response in the ischemic hemisphere via AT1R. In recent years, new components of RAS have been discovered, including ACE2, Angiotensin-(1-7) [Ang-(1-7)] and Mas, which constitute ACE2-Ang-(1-7)-Mas axis. ACE2 converts Ang II to Ang-(1-7), and Ang-(1-7) binds with its receptor Mas, exerting benefical effects in cerebrovascular disease. Through interacting with nitric oxide and bradykinin, Ang-(1-7) could attenuate the development of hypertension and the pathologic progress of atherosclerosis. Besides, its antithrombotic activity also prevents thrombogenic events, which may contribute to reduce the risk of ischemic stroke. In addition, after ischemia insult, ACE2-Ang-(1-7)-Mas has been shown to reduce the cerebral infarct size and improve neurological deficits through its antioxidative and anti-inflammatory effects. Taken together, activation of the ACE2-Ang-(1-7)-Mas axis may become a novel therapeutic target in prevention and treatment of ischemia stroke, which deserves further investigations.Keywords
This publication has 95 references indexed in Scilit:
- Suppressing inflammation by inhibiting the NF‐κB pathway contributes to the neuroprotective effect of angiotensin‐(1‐7) in rats with permanent cerebral ischaemiaBritish Journal of Pharmacology, 2012
- ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertensionCardiovascular Research, 2011
- Sympathoexcitation by Oxidative Stress in the Brain Mediates Arterial Pressure Elevation in Obesity-Induced HypertensionCirculation, 2009
- Angiotensin‐converting enzyme 2 in the brain: properties and future directionsJournal of Neurochemistry, 2008
- Overexpression of ACE2 Enhances Plaque Stability in a Rabbit Model of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- The Antithrombotic Effect of Angiotensin-(1-7) Involves Mas-Mediated NO Release from PlateletsMolecular Medicine, 2008
- Pharmacological Effects of AVE 0991, a Nonpeptide Angiotensin‐(1–7) Receptor AgonistCardiovascular Drug Reviews, 2006
- Antithrombotic Effect of Captopril and Losartan Is Mediated by Angiotensin-(1-7)Hypertension, 2002
- Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient miceJCI Insight, 2000
- Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain.Proceedings of the National Academy of Sciences of the United States of America, 1988